All test subjects regardless of exact test objective or body weight require a priming dose of 50 mL PE012 delivered orally, followed by a one-hour quarantine observation.
Should the subject show macrophenotypic changes in observation (and the planned test isn't to evaluate PE012's effects), the subject is to be terminated and processed, with all reports sent to Administration for archival.
If the subject remained unchanged the testing can proceed after 24 hours of incubation, as per the previous protocol.
Should the subject show macrophenotypic changes in observation (and the planned test isn't to evaluate PE012's effects), the subject is to be terminated and processed, with all reports sent to Administration for archival.
If the subject remained unchanged the testing can proceed after 24 hours of incubation, as per the previous protocol.